Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Braunschweig

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Urology Practice|June 15, 2026
Contemporary Validation of the Renal Cell Carcinoma Inflammatory Score (RISK) for Preoperative Prognostication in Non-Metastatic Renal Cell CarcinomaAdam Braunschweig, Gabriel Ekene Agu, Reza Lahiji, et al.
Urologic Oncology|April 5, 2026
Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinomaReza Lahiji, Luke L Son, Susan Mumford, et al.
World Journal of Urology|July 6, 2026
Sarcopenia is associated with poor survival among patients with non-metastatic renal cell carcinoma and venous tumor thrombusReza Lahiji, Baris Esen, Luke L Son, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Urology Practice|June 15, 2026
Contemporary Validation of the Renal Cell Carcinoma Inflammatory Score (RISK) for Preoperative Prognostication in Non-Metastatic Renal Cell CarcinomaAdam Braunschweig, Gabriel Ekene Agu, Reza Lahiji, et al.
Urologic Oncology|April 5, 2026
Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinomaReza Lahiji, Luke L Son, Susan Mumford, et al.
World Journal of Urology|July 6, 2026
Sarcopenia is associated with poor survival among patients with non-metastatic renal cell carcinoma and venous tumor thrombusReza Lahiji, Baris Esen, Luke L Son, et al.
Pageof 2